Dispatch Bio has dosed the first participant in a Phase I trial aimed at evaluating its new immunotherapy, DISP-10, in...
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop treatments for fibro-inflammatory diseases.The post Mediar...
Alteogen has signed an exclusive licensing deal worth up to $365m with a global pharmaceutical company, granting worldwide rights to...
Azra AI and Blackford have formed a partnership to support the progression from imaging-based detection to care coordination for patients...
SystImmune has dosed the first patient in its global Phase III clinical trial, BrenDeLL-Lung01, assessing BL-M14D1 combined with atezolizumab in...
SOPHiA GENETICS and AstraZeneca are to co-develop and launch two companion diagnostics aimed at supporting precision oncology therapies.The post SOPHiA...
Evexta Bio and Roche have partnered on a Phase Ib study investigating the rupitasertib-giredestrant combination in patients with advanced or...
Phylo has collaborated with Chugai Pharmaceutical to implement the Biomni Lab platform within the latter’s drug discovery operations.The post Phylo...
Integer Holdings is to be acquired by an affiliate of investment funds managed by KKR, in an all-cash deal valuing...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.